|
Guest Column
RFID fights counterfeit menace
RFID is an effective tool to tackle the problem of counterfeiting
prevalent in the pharma industry today. Ravi Mathur presents his views
on the issue
Counterfeit drugs are a huge problem not only for our society but also for
the Pharma industry globally. It most importantly affects the brand equity of
India in global markets as a major exporter and manufacturer of Pharma drugs
and other medical products. The annual cost of counterfeiting to the pharmaceutical
industry is $68 billion.
Electronic Product Code (EPC) or Radio Frequency Identification (RFID) is the
best medicine against counterfeit drugs and item level tagging, which can help
eliminate this problem.
EPC is an innovation, an outcome of extensive research undertaken
by the Auto-ID Center, Massachusetts Institute of Technology (MIT), Boston,
which was funded and sponsored by the USFDA, Baxter, Reckitt Benckiser, Abbott
Labs, Pfizer, Johnson & Johnson, amongst 100 other leading companies across
industry segments.
EPC based RFID technology uses RFID tags affixed on cases
and consignments and a serialised Electronic Product Code for identification,
detection and subsequent segregation of genuine and counterfeit pharma drugs
and medical supplies globally. This would obviously benefit all stakeholderspharma
manufacturers, health regulators and pharma distribution supply chain including
chemists, druggists, stockists most importantly, consumers.
RFID tracking, in general, could help improve the integrity
of the supply chain. Companies can maintain much tighter control over legitimate
shipments by clearly identifying and tracking products, cartons and pellets,
and ensure that they aren't hijacked or stolen. This can prevent products from
falling into the hands of counterfeiters, who could dilute or alter the drugs
and then foist them on unsuspecting pharmacies and consumers.
Much of the effort centers on 'authentication' and 'track
and trace' technologies. The appeal of RFID and EPC technology is the
ability to uniquely identify individual products throughout the supply chain
and create seamless visibility, says Lisa Clowers, Vice President of Supply
Chain Processes & Technology at the Healthcare Distribution Management Association
(HDMA), Reston, Virginia. It is a non-profit organisation, set up in US to secure
safe and effective distribution of healthcare products.
Counterfeit detection and efficient expiration management of pharma drugs and
medical supplies through deployment EPC based RFID technology facilitates higher
quality patient care world-wide. This technology also has possibilities of being
deployed in a big way in India by virtue of its applications in detection of
counterfeit merchandise, asset tracking, and traceability across national and
global supply chains, product recall, arresting of pilferages and shrinkages,
enhanced supply chain efficiencies, wastage control in supply chains.
|
|
| |
2004
|
2005
|
2006
|
2007
|
|
Mass Serialisation of products (Tagging)
|
Feasibility studies for pallets, cases, packages
|
Some pallets, cases, packages for highly Counterfeit
|
Most pallets, cases, packages
for highly counterfeit
Some pallets,
cases for other
|
All Pallets, Cases
Most packages
|
|
RFID Technology Acquisition (Readers)
|
|
Some manufacturers, wholesalers, chain drug stores,
hospitals
|
Most manufacturers, wholesalers,
chain drug stores, hospitals
Some small retailers
|
All manufacturers, wholesalers, chain
drug stores, hospitals
Most small retailers
|
Industry Associations
1. HDMA expects case tagging by 2006 and unit level by 2007
2. NACDS expects pallet and case tagging by 2006 |
The FDA Policy
The organisation that is responsible for regulating pharmaceutical safety in
the USFDA. Since the US is such a huge pharmaceutical market, FDA policy has
a world-wide effect on manufacturers. The story of the French RFID tags on Viagra
therefore begins with a 1988 set of FDA regulations enacted, following the passage
of the Prescription Drug Marketing Act (PDMA) of 1987. In 1987 the Prescription
Drug Marketing Act (PDMA) was written to address the problems of drug counterfeiting
in the pharmaceutical supply chain. Pharmaceuticals pass through many different
points in the distribution chain from the factory to the local pharmacist. This
leaves the system vulnerable to the introduction of counterfeit drugs. For this
reason, the PDMA requires verification of the source of pharmaceutical shipments.
The method of accounting for where a pharmaceutical comes from and verifying
it to be legitimate is called the 'chain of custody'. It has been largely paper-based
for many years.
The FDA has been investigating the use of information technology to make the
chain of custody less labor-intensive and more secure. They issued a report
in February 2004 that discussed various ways of automating the chain-of-custody
'pedigree' of a drug. This report, Combating Counterfeit Drugs - A Report of
The Food and Drug Administration, was the first to propose the use of RFID tags
to create a secure e-pedigree that could be physically tied to each
pharmaceutical unit of sale (box, bottle, blister pack, case, or pallet).
Pfizer and TAGSYS are implementing RFID technology to protect
the pharmaceutical supply chain from counterfeit and black-market drugs. The
launch product for the technology is Pfizer's much-counterfeited Viagra. Other
manufacturers like GlaxoSmithKline and Purdue Pharma have also announced plans
to tag their products. Within India, Ranbaxy has become the first company to
affix EPC/RFID tags in response to Wal-Mart directive effective from 1st January
2005.
Optimising the Supply Chain has also been one of the biggest challenges of the
Healthcare sector. It globally loses $ two billion due to overstock and expiry.
RFID helps in optimising supply chain which would enable to achieve 30 percent
stock reduction, 30 percent increase in value added time and seven percent reduction
in supply chain costs. It also helps in FIFO management, recalls of expired
drugs, real-time tracking of expensive and critical instruments, restrict the
access of drugs to authorized staff, accurate matching of test specimens to
the patients, reduction in medical errors.
Another very big concern area for this sector is medical
errors. (Approx) 75,000 patients die in USA alone each year from medical errors
which is caused by patient misidentification or medication misidentification.
This can be eliminated altogether by the use of RFID tags which can be placed
on test specimens & accurately linked to a patient's records. The Role of
EPCglobal India: EPCglobal India, a division of GS1 India, is a regional Member
Organisation of EPCglobal, the not-for-profit organisation set up to establish
global standards regarding the development, implementation and adoption of Electronic
Product Code (EPC) and Radio Frequency Identification (RFID) technology and
support of the EPCglobal Network.
The Author is the CEO GS1 India. GS1 India has been set
up as a not-for-profit Organisation in 1996 under the Ministry of Commerce,
Government of India and represents a joint Industry-Government collaborative
initiative at bringing global best practices & standards for enhancing efficiency
in Supply Chain Management into India
|